Bormioli Pharma Completes Acquisition of Remy & Geiser GmbH
The acquisition comes after Bormioli became an independent company owned by Triton Investment Fund in December 2017.
Bormioli Pharma, a pharmaceutical and biopharmaceutical plastic containers, closures, and packaging accessories company headquartered in Italy, announced it completed its acquisition of Remy & Geiser (R&G), a German plastic and glass product company.
According to an Oct. 8, 2019 press release, the acquisition comes after Bormioli became an independent company owned by Triton Investment Fund in December 2017.
“This acquisition is part of a wider development plan aimed to make of Bormioli Pharma a truly global and innovative player,” said Andrea Lodetti, CEO, Bormioli, in the press release. “Through this operation Bormioli Pharma reinforces its presence in the German and Northern European markets, expands its current offering with complementary products and strengthens its manufacturing footprint adding more technological capabilities.”
R&G develops, manufactures, and closes sales for dosing systems, pipette droppers, and tubular glass vials, according to the release. The company has about 270 employees and two plants located in Germany.
“We are proud to become a part of a solid and international group like Bormioli Pharma,” added Dr. Friedrich Hillebrand, R&G’s owner, in the press release. “With this step Remy & Geiser achieves further development potential and broadens its future horizons. It is a project I strongly believe in, and I am honored to join the Group as [m]ember of the [b]oard of [d]irectors.”
Bormioli will be at Booth 111C10 and R&G will be at Booth 111C51 at CPhI Worldwide on Nov. 5–7 in Frankfurt, Germany.
Source: Bormioli Pharma
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
